Literature DB >> 11997266

Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells.

Rongbao Zhao1, Feng Gao, I David Goldman.   

Abstract

Although the reduced folate carrier RFC1 and the thiamine transporters THTR-1 and THTR-2 share approximately 40% of their identity in protein sequence, RFC1 does not transport thiamine and THTR-1 and THTR-2 do not transport folates. In the present study, we demonstrate that transport of thiamine monophosphate (TMP), an important thiamine metabolite present in plasma and cerebrospinal fluid, is mediated by RFC1 in L1210 murine leukemia cells. Transport of TMP was augmented by a factor of five in cells (R16) that overexpress RFC1 and was markedly inhibited by methotrexate, an RFC1 substrate, but not by thiamine. At a near-physiological concentration (50 nM), TMP influx mediated by RFC1 in wild-type L1210 cells was approximately 50% of thiamine influx mediated by thiamine transporter(s). Within 1 min, the majority of TMP transported into R16 cells was hydrolyzed to thiamine with a component metabolized to thiamine pyrophosphate, the active enzyme cofactor. These data suggest that RFC1 may be one of the alternative transport routes available for TMP in some tissues when THTR-1 is mutated in the autosomal recessive disorder thiamine-responsive megaloblastic anemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997266     DOI: 10.1152/ajpcell.00547.2001

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  31 in total

1.  Therapy: Vitamin B6, B9 and B12 in diabetic nephropathy--beware.

Authors:  Paul J Thornalley; Naila Rabbani
Journal:  Nat Rev Endocrinol       Date:  2010-09       Impact factor: 43.330

Review 2.  SLC19: the folate/thiamine transporter family.

Authors:  Vadivel Ganapathy; Sylvia B Smith; Puttur D Prasad
Journal:  Pflugers Arch       Date:  2003-05-06       Impact factor: 3.657

3.  A high-affinity and specific carrier-mediated mechanism for uptake of thiamine pyrophosphate by human colonic epithelial cells.

Authors:  Svetlana M Nabokina; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-24       Impact factor: 4.052

Review 4.  Mechanisms of membrane transport of folates into cells and across epithelia.

Authors:  Rongbao Zhao; Ndeye Diop-Bove; Michele Visentin; I David Goldman
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

5.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  SLC19A1 pharmacogenomics summary.

Authors:  Sook Wah Yee; Li Gong; Ilaria Badagnani; Kathleen M Giacomini; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-11       Impact factor: 2.089

7.  High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

Authors:  R Babaei-Jadidi; N Karachalias; C Kupich; N Ahmed; P J Thornalley
Journal:  Diabetologia       Date:  2004-12-11       Impact factor: 10.122

Review 8.  The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.

Authors:  Larry H Matherly; Mike R Wilson; Zhanjun Hou
Journal:  Drug Metab Dispos       Date:  2014-01-06       Impact factor: 3.922

Review 9.  Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.

Authors:  Rongbao Zhao; Larry H Matherly; I David Goldman
Journal:  Expert Rev Mol Med       Date:  2009-01-28       Impact factor: 5.600

10.  Thiamine status in humans and content of phosphorylated thiamine derivatives in biopsies and cultured cells.

Authors:  Marjorie Gangolf; Jan Czerniecki; Marc Radermecker; Olivier Detry; Michelle Nisolle; Caroline Jouan; Didier Martin; Frédéric Chantraine; Bernard Lakaye; Pierre Wins; Thierry Grisar; Lucien Bettendorff
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.